Abiomed Announces Record Revenue of $38.8 Million, Up 42% and Worldwide Impella Revenue Growth of 56%

Published: Aug 02, 2012

DANVERS, Mass., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2013 revenue of $38.8 million, up 42% compared to revenue of $27.4 million in the same period of fiscal 2012, and GAAP net income of $3.1 million or $0.08 per diluted share in the first quarter of fiscal 2013, compared to GAAP net loss of $4.6 million or a loss of $0.12 per basic and diluted share in the same period of fiscal 2012.

Back to news